Generali Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Generali Asset Management's ELV Position: Q2 2026 in Review
Generali Asset Management increased its Elevance Health (ELV) stake by 129% in Q2 2026, buying an estimated $9.03M and bringing the position to 43,226 shares worth $16.7M. The position accounts for 0.3% of the portfolio, ranked #77.
Generali Asset Management first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Generali Asset Management held 43,226 shares of Elevance Health worth $16.7M as of Q2 2026.
- Generali Asset Management bought 24,350 Elevance Health shares in Q2 2026, an estimated $9.03M.
- Elevance Health made up 0.3% of Generali Asset Management's portfolio in Q2 2026, its #77 holding.
- Generali Asset Management first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.